Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Opportunity Analysis and Industry Forecast, 2018 - 2025
- ALL2963640
- 225 Pages
- March 2019
- Medical Devices
The global proteomics market has witnessed significant growth over the past few years, owing to increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market. However, stringent regulatory approvals, high cost of instruments, and dearth of qualified researchers are expected to hamper the market growth.
The global proteomics market is segmented based on component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is subsegmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry.
Likewise, the chromatography segment is subclassified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global proteomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
• The report provides a quantitative analysis for the period of 2017–2025 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market by components helps to understand the various types of instruments used across geographies.
• Comprehensive analysis of all regions is provided to determine the prevailing opportunities in these regions.
• Key market players have been profiled in the report and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market.
• Extensive analysis of the market is conducted by closely following key product positioning, and monitoring the top contenders within the market framework.
Key Market Segments
By Component
• Instruments
o Microarray
o Spectrometry
Mass Spectrometry
NMR Spectrometry
o X-ray Crystallography
o Chromatography
HPLC Systems
Ion Chromatography
Affinity Chromatography
Supercritical Fluid Chromatography
o Electrophoresis
o Surface Plasmon Resonance
o Protein Fractionation Reagents
• Reagents
o Microarray
o Spectroscopy
o X-ray Crystallography
o Chromatography
o Electrophoresis
o Immunoassay
o Protein Fractionation Reagents
• Services
By Application
• Drug Discovery
• Disease Diagnosis
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in popularity of personalized medicines
3.4.1.2. Upsurge in R&D expenditure
3.4.1.3. Technological advancements associated with proteomics components
3.4.2. Restraints
3.4.2.1. High costs associated with proteomics components
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities associated with biomarker identification
3.4.3.2. Developments in mass spectrometry-based proteomics
Chapter: 4: PROTEOMICS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Microarray
4.2.3.1. Market size and forecast
4.2.4. Spectrometry
4.2.4.1. Market size and forecast
4.2.5. X-ray crystallography
4.2.5.1. Market size and forecast
4.2.6. Chromatography
4.2.6.1. Market size and forecast
4.2.7. Electrophoresis
4.2.7.1. Market size and forecast
4.2.8. Immunoassay
4.2.8.1. Market size and forecast
4.2.9. Protein fractionation reagents
4.2.9.1. Market size and forecast
4.2.10. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Microarray
4.3.3.1. Market size and forecast
4.3.4. Spectrometry
4.3.4.1. Market size and forecast
4.3.4.1.1. Mass spectrometry
4.3.4.1.1.1. Market size and forecast
4.3.4.1.2. NMR spectrometry
4.3.4.1.2.1. Market size and forecast
4.3.5. Chromatography
4.3.5.1. Market size and forecast
4.3.5.1.1. HPLC systems
4.3.5.1.1.1. Market size and forecast
4.3.5.1.2. Ion chromatography
4.3.5.1.2.1. Market size and forecast
4.3.5.1.3. Affinity chromatography
4.3.5.1.3.1. Market size and forecast
4.3.5.1.4. Supercritical fluid chromatography
4.3.5.1.4.1. Market size and forecast
4.3.6. Electrophoresis
4.3.6.1. Market size and forecast
4.3.7. Surface plasmon resonance
4.3.7.1. Market size and forecast
4.3.8. X-ray crystallography
4.3.8.1. Market size and forecast
4.3.9. Protein fractionation systems
4.3.9.1. Market size and forecast
4.3.10. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
Chapter: 5: PROTEOMICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug discovery
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Disease diagnosis
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
Chapter: 6: PROTEOMICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. proteomics market, by component
6.2.2.1.2. U.S. proteomics market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada proteomics market, by component
6.2.2.2.2. Canada proteomics market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico proteomics market, by component
6.2.2.3.2. Mexico proteomics market, by application
6.2.3. North America proteomics market, by component
6.2.4. North America proteomics market, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany proteomics market, by component
6.3.2.1.2. Germany proteomics market, by application
6.3.2.2. France
6.3.2.2.1. France proteomics market, by component
6.3.2.2.2. France proteomics market, by application
6.3.2.3. UK
6.3.2.3.1. UK proteomics market, by component
6.3.2.3.2. UK proteomics market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy proteomics market, by component
6.3.2.4.2. ITALY proteomics market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain proteomics market, by component
6.3.2.5.2. Spain proteomics market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe proteomics market, by component
6.3.2.6.2. Rest of Europe proteomics market, by application
6.3.3. Europe proteomics market, by component
6.3.4. Europe proteomics market, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.1.1. Japan
6.4.1.1.1. Japan proteomics market, by component
6.4.1.1.2. Japan proteomics market, by application
6.4.1.2. China
6.4.1.2.1. China proteomics market, by component
6.4.1.2.2. China proteomics market, by application
6.4.1.3. India
6.4.1.3.1. India proteomics market, by component
6.4.1.3.2. India proteomics market, by application
6.4.1.4. Australia
6.4.1.4.1. Australia proteomics market, by component
6.4.1.4.2. Australia proteomics market, by application
6.4.1.5. South Korea
6.4.1.5.1. South Korea proteomics market, by component
6.4.1.5.2. South Korea proteomics market, by application
6.4.1.6. Rest of Asia-Pacific
6.4.1.6.1. Rest of Asia-Pacific proteomics market, by component
6.4.1.6.2. Rest of Asia-Pacific proteomics market, by application
6.4.2. Asia-Pacific proteomics market, by component
6.4.3. Asia-Pacific proteomics market, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil proteomics market, by component
6.5.2.1.2. Brazil proteomics market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia proteomics market, by component
6.5.2.2.2. Saudi Arabia proteomics market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa proteomics market, by component
6.5.2.3.2. South Africa proteomics market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA proteomics market, by component
6.5.2.4.2. Rest of LAMEA proteomics market, by application
6.5.3. LAMEA proteomics market, by component
6.5.4. LAMEA proteomics market, by application
Chapter: 7: COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. DANAHER CORPORATION (BECKMAN COULTER, INC.)
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. LI-COR, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. PERKINELMER INC.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. THERMO FISHER SCIENTIFIC, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. HORIBA, LTD.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. BIO-RAD LABORATORIES, INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product type Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. BRUKER CORPORATION (BECKMAN COULTER, INC.)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product type portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. GE HEALTHCARE (GENERAL ELECTRIC)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. WATERS CORPORATION (BECKMAN COULTER, INC.)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product type portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
TABLE 01. GLOBAL PROTEOMICS REAGENTS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 02. PROTEOMICS REAGENTS MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 03. PROTEOMICS REAGENTS MARKET, BY COMPONENT TYPE, 2017–2025 ($MILLION)
TABLE 04. PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 05. PROTEOMICS INSTRUMENTS MARKET, BY COMPONENT TYPE, 2017–2025 ($MILLION)
TABLE 06. PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, BY TYPE, 2017–2025 ($MILLION)
TABLE 07. PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2017–2025 ($MILLION)
TABLE 08. PROTEOMICS SERVICES MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 09. GLOBAL PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 10. PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2017–2025 ($MILLION)
TABLE 11. PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2017–2025 ($MILLION)
TABLE 12. PROTEOMICS MARKET FOR OTHERS, BY REGION, 2017–2025 ($MILLION)
TABLE 13. PROTEOMICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 14. NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 15. U.S. PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 16. U.S. PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 17. CANADA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 18. CANADA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 19. MEXICO PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 20. MEXICO PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 21. NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 22. NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 23. EUROPE PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 24. GERMANY PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 25. GERMANY PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 26. FRANCE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 27. FRANCE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 28. UK PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 29. UK PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 30. ITALY PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 31. ITALY PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 32. SPAIN PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 33. SPAIN PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 34. REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 35. REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 36. EUROPE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 37. EUROPE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 38. ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 39. JAPAN PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 40. JAPAN PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 41. CHINA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 42. CHINA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 43. INDIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 44. INDIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 45. AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 46. AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 47. SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 48. SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 51. ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 52. ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 53. LAMEA PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 54. BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 55. BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 56. SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 57. SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 58. SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 59. SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 60. REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 61. REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 62. LAMEA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 63. LAMEA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 64. AGILENT: COMPANY SNAPSHOT
TABLE 65. AGILENT: OPERATING SEGMENTS
TABLE 66. AGILENT : PRODUCT PORTFOLIO
TABLE 67. DANAHER: COMPANY SNAPSHOT
TABLE 68. DANAHER: OPERATING SEGMENTS
TABLE 69. DANAHER: PRODUCT PORTFOLIO
TABLE 70. LI-COR, INC.: COMPANY SNAPSHOT
TABLE 71. LI-COR, INC.: OPERATING SEGMENTS
TABLE 72. LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 73. PERKINELMER: COMPANY SNAPSHOT
TABLE 74. PERKINELMER: OPERATING SEGMENTS
TABLE 75. PERKINELMER: PRODUCT PORTFOLIO
TABLE 76. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 77. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 78. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79. HORIBA: COMPANY SNAPSHOT
TABLE 80. HORIBA: BUSINESS SEGMENTS
TABLE 81. HORIBA: PRODUCT PORTFOLIO
TABLE 82. BIO-RAD: COMPANY SNAPSHOT
TABLE 83. BIO-RAD: OPERATING SEGMENTS
TABLE 84. BIO-RAD: PRODUCT TYPE PORTFOLIO
TABLE 85. BRUKER: COMPANY SNAPSHOT
TABLE 86. BRUKER: OPERATING SEGMENTS
TABLE 87. BRUKER: PRODUCT TYPE PORTFOLIO
TABLE 88. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 89. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 90. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 91. WATERS: COMPANY SNAPSHOT
TABLE 92. WATERS: OPERATING SEGMENTS
TABLE 93. WATERS: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
